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Abstract
Since genomic data are widely available, many strategies have been implemented to
reveal  the  function  of  specific  nucleotides  or  amino  acids  in  promoter  regions  or
proteins, respectively. One of the methods most commonly used to determine the impact
of mutations is the site‐directed mutagenesis using the polymerase chain reaction (PCR).
There are  different  published protocols  to  develop single  or  multiple  site‐directed
mutagenesis. In this chapter, we reviewed the enzymes commonly used in site‐directed
mutagenesis, the methods for simple and multiple site‐directed mutagenesis in large
constructs, mediated by insertion of restriction sites. Other methods reviewed include
high‐throughput site‐directed mutagenesis using oligonucleotides synthesized on DNA
chips, and those based on multi‐site‐directed mutagenesis, based on recombination.
Software tools to design site‐directed mutagenesis primers are also presented.
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1. Introduction
With the advent of new technologies during the last decade, an important amount of genomic
data has been provided by next‐generation sequencing. With the information provided by
genomic sequences, many gene polymorphisms, insertions, or deletions have been significantly
associated with disorders that include mono‐ and polygenetic diseases to cancer. However, to
demonstrate that these mutations, located either in coding or uncoding regions, are involved in
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the illness, it is necessary to evaluate them in a simpler context using other molecular strategies.
Taking the advantage of direct manipulation of DNA as well the availability of sequences, site‐
directed mutagenesis using polymerase chain reaction (PCR) has become an essential tool for
studies of key sequences in regulatory regions and/or the relationship between the structure
and function of proteins. Many strategies have been developed to simplify the method and
increase its efficiency. Commonly, site‐directed mutagenesis is used to introduce mutations in
a DNA fragment, genome or plasmid, either by PCR or restriction endonucleases digestion. In
this chapter, we summarized different strategies to perform the site‐directed mutagenesis using
PCR.
2. Site‐directed mutagenesis
Mutagenesis is usually employed to understand the regulatory regions of genes and the
relationship between the protein structure and its function [1]. Depending on the number of
sites to be mutated, site‐directed mutagenesis can be divided into two types: simple or multiple
mutations [2]. For single mutations, methods are based on the amplification of double‐stranded
DNA from plasmids using complementary oligonucleotides carrying the mutation of interest
[3]. Due to its simplicity, the low number of hours spent, and high efficiency, this is one of the
most common strategies to introduce mutations in DNA fragments. For multiple mutations,
methods incorporate the desired mutations simultaneously in the same reaction or they are
obtained after several rounds of mutations.
There are a number of commercial kits for simple mutagenesis. These kits are easy to use but
regularly have trouble getting large deletions [4]. With the intention of overcoming the
limitations of commercial kit, other methods have been developed for other applications [5].
2.1. Enzymes used in site‐directed mutagenesis
To ensure an accurate amplification by PCR, versions of the high‐fidelity DNA polymerases
are usually available for site mutagenesis. The common trait of this kind of polymerases is
their low error rate. High‐fidelity DNA polymerases contain a proofreading domain consisting
of polymerase activity 5’‐3’ and exonuclease activity 3’‐5’ to remove wrong incorporated
nucleotides. Table 1 shows the most representative enzymes to amplify DNA by PCR.
The DNA polymerases PfuTurbo and KOD are very useful to amplify products with comple‐
mentary primers, however, Phusion DNA polymerase and others cannot. The failure probably
is due that Phusion requires high annealing temperatures, and it is able to promote the
formation of a perfect matching of complementary primers more than the formation of the
primer‐template duplex containing mismatches [6].
Another important part of site‐directed mutagenesis is eliminating the template with a
methylation‐recognizing‐nuclease, as DpnI. Although digestion of DpnI can eliminate fully
methylated parental DNA, around 20–30% of hemimethylated molecules (parental strand
combined with PCR‐generated strand) could not be removed due to hemimethylated DNA,
and the PCR product would be more resistant to DpnI [7].
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Enzyme Published error rate (errors/bp/duplication) Fidelity relative to Taq
Taq 1–20 × 10‐5 1×
AccuPrime‐ Taq, HF N/A 9× better
KOD N/A 4× better, 50× better
Pfu 1–2 × 10‐6 6–10× better
Phusion hot start 4 × 10‐7 (HF buffer), >50× better (HF buffer),
9.5 × 10‐7 (GC buffer) 24× better (GC buffer)
Source: Taken from McInerney et al. (2014) [8].
Table 1. Published fidelity (error rate) values for DNA polymerases.
2.1.1. PhusionTM high‐fidelity DNA polymerase
This enzyme is manufactured by New England Biolabs, Phusion high‐fidelity DNA polymer‐
ase is recommended for DNA amplification with high fidelity and robust performance. This
DNA polymerase has a unique structure obtained from a fusion of the dsDNA‐binding domain
to a Pyrococcus‐like proofreading polymerase. The error rate reported by the provider webpage
is 50‐fold lower than that of Taq DNA polymerase and sixfold lower than that of Pyrococcus
furiosus DNA polymerase [9]. This polymerase generates blunt‐ended products and can
amplify from GC‐rich templates.
2.1.2. Q5® High‐fidelity DNA polymerase
This recombinant enzyme is also produced by New England Biolabs, and described with both,
fidelity and robust performance. According to providers webpage, Q5 DNA polymerase is
composed of a novel polymerase fused to Sso7d DNA binding domain. Its error rate is >100‐
Figure 1. Comparison of fidelity rate among high fidelity DNA polymerases. Modified from: https://www.neb.com/
products/pcr‐polymerases‐and‐amplification‐technologies/q5‐high‐fidelity‐dna‐polymerases/q5‐high‐fidelity‐dna‐pol‐
ymerases.
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fold lower than that of Taq DNA polymerase and 12‐fold lower than that Pyrococcus furiosus
(Pfu) DNA polymerase (Figure 1). This polymerase has been optimized with a buffer system
to allow a robust amplification in GC‐rich regions. Moreover, New England Biolabs webpage
has included a Tm calculator to determine the appropriate annealing temperature for primers
in GC‐rich regions.
2.1.3. AccuPrimeTM Pfx
This product is a preparation of DNA polymerase obtained from Thermococcus species strain
KOD [10, 11]. ThermoFisher Scientific mentions that this polymerase is highly processive and
possesses a fast chain extension capability. The preparation contains an antibody bound to the
inactive polymerase at ambient temperatures, but it dissociates after the initial denaturation
step at 94°C.
2.1.4. PfuUltra high‐fidelity DNA polymerase
The PfuUltra high‐fidelity DNA polymerase (Agilent Technologies, La Jolla, CA, USA) is a
formulation of a genetically engineered mutant of Pfu DNA polymerase and the ArchaeMaxx
polymerase‐enhancing factor. According to the manufacturer, this enzyme exhibits an average
error rate threefold lower than PfuTurbo DNA polymerase and 18‐fold lower than Taq DNA
polymerase. PfuUltra high‐fidelity DNA polymerase is described and it provides a robust
amplification of long and complex genomic targets. The ArchaeMaxx factor eliminates dUTP,
a PCR inhibitor, and promotes shorter extension times, higher yield, and greater target length
capabilities. In fact, the ArchaeMaxx factor functions as a dUTPase.
2.2. Endonuclease DpnI
The use of DpnI endonuclease, which is able to cut methylated DNA, has enabled progress on
site‐directed mutagenesis. Plasmid DNA extracted from bacteria contains methylated DNA,
which makes it susceptible to DpnI enzyme [12], whereas the DNA amplified by PCR does not
contain methylated DNA. Based on this principle, the PCR using plasmid DNA as template is
useful for the in vitro replication and mutagenesis and DpnI digestion. PCR products digest‐
ed by DpnI have been widely used in mutagenesis.
2.3. Site‐directed mutagenesis in large constructs
The QuikChange mutagenesis kits (Agilent Technologies) have become the standard to
develop site‐directed mutagenesis due to the simplicity of their protocols and their high
efficiency. The single‐site mutagenesis approach use a pair of complementary mutagenic
primers to amplify a target plasmid [2]. The main problem in mutagenesis with large inserts
(up to 2100 bp) is due to the efficiency, which is lower than small and medium inserts. In this
case, one limitation for site‐directed mutagenesis is the size of the target plasmid. The factors
that may affect the efficiency of the method are focused on the quality and efficacy of the
polymerases and primers used [13].
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Wang et al. [14] have described a method to generate site‐directed mutagenesis in large genes.
The method consists of two PCR products with four primers (containing mutations and
restriction enzyme sites). Fragments are transiently ligated into TA cloning vectors, and, after
cutting with appropriate enzymes, fragments are ligated into a final vector (Figure 2).
Figure 2. Schematic diagram for site‐directed mutagenesis in large constructs. Two target gene segments are amplified
from template DNA by PCR using four primers, including two flanking primers (a and d). Restriction enzyme sites (R1
and R4) are incorporated. The mutation of interest (indicated by a star) and/or a same‐sense mutation are introduced
to create restriction enzyme sites (R2 and R3). Next, PCR fragments are TA‐subcloned into T‐vectors, and one fragment
is cut (R1 and R2) and inserted into the T‐vector (predigested by R1 and R3) containing another fragment.
Munteanu et al. [13] used the KOD Hot Start polymerase in combination with high perform‐
ance liquid chromatography purified primers to achieve site‐directed mutagenesis in big
plasmid (up to 16 kb). The procedure allowed the incorporation of single or multiple base
changes using 6 cycles of PCR instead of 18.
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2.4. Site‐directed mutagenesis mediated by insertion of restriction sites
The method described by Rouached et al. [15] takes the advantage of the plasticity of the
genetic code and the use of compatible restriction sites (Figure 3). Method is developed in
two steps. First, target DNA is subcloned in a vector, which is the template for the next two
PCRs. One reaction amplifies from the start codon to mutagenized site that contains the
new introduced restriction site. The other reaction amplifies from the mutagenized site con‐
Figure 3. Mutagenesis strategy by restriction enzyme site insertion. Panel A, Two PCR products are obtained from the
full length coding sequence. Mutations, including the restriction enzyme site, are contained in primers b and c. PCR
product are subcloned by separate in cloning vectors. Next, two fragments are digested with the appropriate enzyme
and ligated to reassemble by in‐frame coding sequence. Panel B, example of amino acid substitution after introduction
of BglII restriction site.
Polymerase Chain Reaction for Biomedical Applications164
taining the restriction site to the end of the coding sequence. After amplification, PCR prod‐
ucts are digested with the appropriate enzyme and ligated. Primers containing the
restriction site are partially overlapped to allow an in‐frame assembly of the whole coding
sequence [15].
Zhang et al. [16] reported a method of site‐directed mutagenesis where they introduced
restriction enzyme sites to facilitate the mutant screening (Figure 4). The method uses a dsDNA
plasmid as a template. In order to select the restriction enzyme sites to be introduced, authors
translate the DNA sequence into amino acid sequence, and afterward the amino acid sequence
is reversely translated into DNA sequence again with degenerate codons. This approach allows
selection of a large number of sequences with silent mutations, which contains several
restriction enzyme sites. The transformants are screened by digesting with the appropriate
enzyme [16].
Figure 4. Schematic diagram of the site‐directed mutagenesis introducing a restriction enzyme site. Primers contain a
new restriction enzyme site. Next to PCR assay, product is phosphorylated and ligated to be transformated in a E. coli
strain. After restriction enzyme digestion (XhoI), plasmid is selected to be sequenced. PNK, polynucleotide kinase; RE,
restriction endonuclease.
2.5. High‐throughput site‐directed mutagenesis using oligonucleotides synthesized on
DNA chips
In order to generate a series of constructs with multiple mutants unlimited by the cost of oli‐
gonucleotides, Saboulard et al. [17] described the first generation of a library of single and
multiple site‐directed mutants using a mixture of oligonucleotides synthesized on DNA
chips (Figure 5). They used the human interleukin15 gene as a model. The library produced
96 different clones in 37 different codons using pools of oligonucleotides. Authors described
this approach as straightforward and flexible way to address resolve the problem of massive
mutagenesis after successive rounds [17].
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Figure 5. Strategy for massive mutagenesis using oligonucleotides synthesized on DNA chips. The oligonucleotides
have been synthesized in situ by microprojection on chips. These oligonucleotides, eluted as a mix, are purified and
phosphorylated. Next, target plasmid is amplified in a single‐strand with the mutagenic oligonucleotides. The ampli‐
fied product is digested using DpnI, dialyzed and transformed in E. coli. Several successive rounds can be performed.
Analysis of the clones is made by sequencing and/or by PCR and restriction analysis. Taken from Saboulard et al. [17].
2.6. Methods for multiple site‐directed mutagenesis
Fushan et al. [18] developed a method to introduce multiple and complex mutations on
plasmids without intermediate subcloning. The procedure is depicted in Figure 6. By sequen‐
tial rounds, each one with PCR amplification with two nonoverlapping pair of primers, the
mutation is introduced at the 5’ end of one or both internal primers. Next, PCR products are
mixed and ligated to be amplified with external primers. These external primers are suppres‐
sion adapters to limit the amplification only to target DNA. In order to generate other muta‐
tions, an aliquot of the previous reaction is used as a template [18].
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Figure 6. Schematic representation of site‐directed mutagenesis by amplification, ligation and suppression PCR. Target
DNA is amplified by using two pairs of primers (SO1, IR1, SO2 and IF1). Mutations are on the 5’ end of IR1. After
amplification, DNA fragments are ligated generating different types of products (right panel). Then, DNA is amplified
with suppression primers SO1 and SO2 where predominant products are type C molecules. After first round of muta‐
genesis, an aliquot of product is used to the next round to introduce a new mutation. After multiples rounds, the final
product is digested with restriction enzymes to be subcloned in a vector.
Another method to generate multiple site‐directed mutagenesis is that developed by Holland
et al. [19]. They named their method as AXM mutagenesis. Scheme of Holland’s method is
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shown in Figure 7. By PCR, using a prone‐error polymerase, a large and mutated DNA
fragment is generated with a modified primer containing phosphorothioate linkage at 5’ end.
After amplification, a bacteriophage T7‐exonuclease treatment allows the removal of strand
synthesized with the nonmodified primer. The resulting PCR product is a megaprimer, which
is used in a subsequent mutagenesis reaction. The DNA base excision repair pathway in
Escherichia coli favors the nucleotide base‐change to DNA synthesized by megaprimer instead
of the complementary uracilated DNA sequence [3, 19]. The method facilitates a rapid
generation of multiple mutagenic sites in parallel. A recently modified method of this proce‐
dure has been published, where the Eco29k I enzyme is incorporated to selectively degrade
the original DNA [3].
Figure 7. Schematic procedure of AXM mutagenesis. An error‐prone PCR (EP‐PCR) reaction using a reverse primer
containing phosphorothioate linkages on its 5’ end is carried out. The double‐stranded DNA is treated with T7 exonu‐
clease to selectively degrade the unmodified strand of the dsDNA molecule. The resulting megaprimer is then an‐
nealed to the uracilated, circular, single‐stranded phagemid DNA and used to prime in vitro synthesis by DNA
polymerase. The final product is transformed into E. coli AXE688 cells, where the uracilated strand is removed by the
uracil N‐glycosylase, allowing the survival of the newly synthesized, recombinant strand generated by the megaprim‐
er. The Eco29k I enzyme selectively degrades the original DNA retaining Eco29k I recognition sites.
2.7. Methods for multi‐site‐directed mutagenesis based on recombination
Trehan et al. [20] reported a method named REPLACR‐mutagenesis (recombineering of
Ends of linearized PLAsmids after PCR), which is able to create mutations (substitutions,
deletions and insertions) in plasmids by in vivo recombineering (Figure 8). REPLACR‐
mutagenesis requires the transformation of PCR products in bacteria expressing Red/ET
recombineering proteins. This method can used a variety of plasmids up to bacterial artificial
chromosomes [20].
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Figure 8. Principle of REPLACR‐mutagenesis and primer design strategy for sequence substitution, insertion or dele‐
tion. (A) Primers containing the desired mutation overlap for recombination. Bacteria expressing the recombineering
proteins (Redγ, β, α and RecA) are transformed with the PCR product. Recombination takes places inside the bacteria
and after extraction of plasmid, mutations are confirmed by PCR and sequencing. (B) Example of forward and reverse
primers contains the desired addition/substitution. (C) Example for generating deletion mutants, where the forward
primer contains the sequence adjoining the sequence to be deleted, and the reverse primer contains a sequence homol‐
ogous to the forward primer and the adjoining sequence in the vector.
Liang et al. [2] developed a method for the simultaneous introduction of up to three mutations
in a plasmid DNA via homologous recombination. The strategy is depicted in Figure 9, and it
is compatible with a variety of mutations, including degenerate codons in plasmids of different
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sizes [2]. The procedure consists of a single multiplex or three independent PCR assays. Each
pair of primers contains the desired mutation. Final PCR products have homology at end‐
terminal to be recombinated. After PCR, a 15‐min pulse of recombination activity is carried
out and sample is transformed in E. coli.
Figure 9. Strategy for multi‐site‐directed mutagenesis by homologous recombination. Numbers denote the mutation
sites. To introduce three mutated sites, typically three pairs of overlapping forward and reverse primers are used un‐
less a pair of long primers is used to cover the mutation sites that are in very close proximity.
2.8. Software tools to design site‐directed mutagenesis primers introducing “silent”
restriction sites
The critical points of site‐directed mutagenesis are the primer design and the annealing
temperature. Specific software programs, such as Primer Generator and SiteFind [21, 22], can
be used for the design of a restriction enzyme site within the mutation primers without altering
the translated amino acid sequence [12].
For example, SiteFind allows the introduction of a restriction site near to the point mutation
in manner such that the restriction site has no effect on the peptide sequence. Based on the
redundancy of genetic code, a peptide can be encoded by different DNA sequences. Then, the
novel restriction site can be used as a marker to be easily screened [22]. The software can work
with sequences up to 400 bp.
Another program developed is SDM‐Assist, which creates primers to site‐directed mutagen‐
esis based on their thermodynamic characteristics. The primer contains the desired mutation
and a restriction site for identification of mutant constructs. The algorithm consider factors
such as Tm, GC content, and secondary structure [23].
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2.9. Conclusion—key results
The site‐directed mutagenesis using PCR has been used in molecular biology to modify gene
sequences. Methods described here have allowed the introduction of single or multiple
mutations into the same target. Despite the wide range of commercial kits for site‐directed
mutagenesis, there is a constant search to improve the efficiency and simplicity, with a
concomitant reducing of costs.
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